首页> 外文期刊>Journal of Nephropathology >Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program
【24h】

Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program

机译:一项与生活有关的肾脏移植计划中早期慢性同种异体肾病的患病率和危险因素

获取原文
           

摘要

Background: Chronic allograft nephropathy (CAN) is a common cause of delayed allograft failure throughout the world. Its prevalence and risk factors vary depending on a number of factors. There is little information on the prevalence and risk factors for early CAN in live related renal transplant patients. Objectives: We aimed to determine the prevalence and the risk factors of early CAN in our setup. Patients and Methods: The study was conducted at Sindh Institute of Urology & Transplantation (SIUT), Karachi, from 2002 to 2005 on patients who had live related kidney transplantation and underwent at least one allograft biopsy within 18 months of transplantation. The biopsies were performed and prepared in accordance with established indications and guidelines. The Banff 97 classification and its updates were used to diagnose and categorize the biopsy pathology. Patients were divided into two groups depending on the presence or absence of CAN on biopsies. Following parameters were compared among the groups: age, sex, human leukocyte antigen (HLA) match, immunosuppression used, acute rejection (AR) episodes, urinary tract infections (UTIs), viral infections, cyclosporine levels, early and late graft function monitored by serum creatinine. Results: A total of 164 patients fulfilled the study inclusion criteria. The mean age of recipients and donors was relatively young. The majority of the donors were siblings. The overall prevalence of CAN was 25.6% (42/164), between 3 and 18 months post transplantation. The median time to the appearance of CAN was 9 months post-transplant. The prevalence of CAN increased as post-transplant duration increased. In 39 (92.8%) subjects, CAN was detected on the second or subsequent graft biopsy. Only 3 (7.2%) patients showed CAN on the first graft biopsy. The majority of cases belonged to moderate degree or grade II CAN. The mean serum creatinine values were higher in the CAN group at the time of discharge and all times post-transplantation. Conclusions: In conclusion, the results show that serum creatinine at the time of discharge is a useful predictor of later development of chronic changes in the allograft. Further studies are needed to identify the risk factors for the early development of chronic changes in living related renal transplant program
机译:背景:慢性同种异体肾病(CAN)是全世界同种异体移植延误失败的常见原因。其患病率和危险因素取决于许多因素。有关活体肾移植患者早期CAN的患病率和危险因素的资料很少。目标:我们旨在确定早期CAN的患病率和风险因素。患者和方法:该研究于2002年至2005年在卡拉奇信德大学泌尿外科与移植研究所(SIUT)进行,该患者是活体相关肾脏移植并且在移植后18个月内至少进行了一次同种异体活检。根据确定的适应症和指南进行和准备活检。班夫97分类及其更新用于对活检病理进行诊断和分类。根据活检组织中是否存在CAN,将患者分为两组。在各组之间比较以下参数:年龄,性别,人类白细胞抗原(HLA)匹配,使用的免疫抑制,急性排斥(AR)发作,尿路感染(UTI),病毒感染,环孢菌素水平,早期和晚期移植物功能监测血清肌酐。结果:共有164位患者符合研究纳入标准。受助者和供者的平均年龄相对较小。大多数捐助者是兄弟姐妹。在移植后3到18个月之间,CAN的总体患病率为25.6%(42/164)。出现CAN的中位时间为移植后9个月。 CAN的患病率随着移植后持续时间的增加而增加。在39名(92.8%)受试者中,在第二次或以后的移植活检中检测到CAN。第一次移植活检中只有3名(7.2%)患者显示CAN。大多数病例属于中度或二级CAN。出院时和移植后所有时间,CAN组的平均血清肌酐值均较高。结论:总之,结果表明,出院时的血清肌酐是同种异体移植慢性变化以后发展的有用预测指标。需要进一步的研究来确定与生活有关的肾脏移植计划中慢性变化的早期发展的危险因素

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号